Successful GLP-1R products in 2023 included Novo Nordisks Ozempic and Wegovy, which generated $13.9 billion and $4.6 billion, respectively, as well as Eli Lillys Trulicity and Mounjaro, which generated $7.1 billion and $5.1 billion. Over the next seven years, the GLP-1R market is expected to expand to 35 approved products from 16 companies
10.1104/pp.111.184531 Plant Physiol
Transformation efficiency remains low due to the rigid chitin-rich cell wall, heterogeneous tissue organization, and complex life cycles, which hinder DNA delivery and stable integration
Brain Injury , 1-10
2.2 GLP-1R and tau protein hyperphosphorylation Hyperphosphorylated tau is a major component of intracellular neurofibrillary tangles (NFTs), which, together with amyloid plaques, are a distinguishing marker of AD (Tracy et al., 2022
So always start slowly, look at the dosage, increase gradually